[CBAY] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
09-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -3.09%
YoY- -96.34%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -23,222 -10,726 -24,038 -17,531 -8,929 -6,992 -1,357 60.45%
Tax 0 -614 1,610 42 -781 -22 5,492 -
NP -23,222 -10,726 -24,038 -17,531 -8,929 -6,992 -1,357 60.45%
Tax Rate - - - - - - - -
Total Cost 23,222 10,726 24,038 17,531 8,929 6,992 1,357 60.45%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -0.34 -0.16 -0.35 -0.30 -0.31 -0.30 -0.09 24.77%
EPS Diluted -0.34 -0.16 -0.35 -0.30 -0.31 -0.30 -0.09 24.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.